scPharmaceuticals Inc (NASDAQ: SCPH) is -8.10% lower on its value in year-to-date trading and has touched a low of $1.94 and a high of $5.65 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SCPH stock was last observed hovering at around $4.04 in the last trading session, with the day’s loss setting it -0.07%.
Currently trading at $3.97, the stock is -0.69% and 17.86% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.18 million and changing -1.73% at the moment leaves the stock 13.49% off its SMA200. SCPH registered 12.15% gain for a year compared to 6-month gain of 13.43%.
The stock witnessed a 3.12% loss in the last 1 month and extending the period to 3 months gives it a 58.80%, and is -0.25% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.85% over the week and 5.20% over the month.
scPharmaceuticals Inc (SCPH) has around 164 employees, a market worth around $209.58M and $41.98M in sales. Profit margin for the company is -216.24%. Distance from 52-week low is 104.64% and -29.73% from its 52-week high. The company has generated returns on investments over the last 12 months (-193.25%).
The EPS is expected to grow by 47.02% this year
The shares outstanding are 50.28M, and float is at 35.96M with Short Float at 5.08%.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 5.56 million shares valued at $24.18 million. The investor’s holdings represent 14.2608 of the SCPH Shares outstanding. As of 2024-06-30, the second largest holder is RUBRIC CAPITAL MANAGEMENT LP with 3.52 million shares valued at $15.33 million to account for 9.042 of the shares outstanding. The other top investors are AIGH CAPITAL MANAGEMENT LLC which holds 3.5 million shares representing 8.9891 and valued at over $15.24 million, while KING LUTHER CAPITAL MANAGEMENT CORP holds 5.6564 of the shares totaling 2.21 million with a market value of $9.59 million.
scPharmaceuticals Inc (SCPH) Insider Activity
The most recent transaction is an insider purchase by ORBIMED ADVISORS LLC, the company’s 10% Owner. SEC filings show that ORBIMED ADVISORS LLC bought 500,000 shares of the company’s common stock on Aug 13 ’24 at a price of $4.00 per share for a total of $2.0 million. Following the purchase, the insider now owns 5.81 million shares.
